FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076756910> ?p ?o ?g. }

• W2076756910 endingPage "75" @default.
• W2076756910 startingPage "67" @default.
• W2076756910 abstract "After a previous analysis that did not detect clear differences in the results of three conditioning regimens used for autologous stem cell transplantation (ASCT) in patients from the Spanish Registry for Transplant in Multiple Myeloma (MM), we have updated the registry, including a larger number of cases and a fourth conditioning regimen with a longer follow-up. We evaluate 472 MM patients treated with 200 mg/m2 melphalan (MEL200), 135 patients treated with 140 mg/m2 melphalan plus total body irradiation [(MEL140 + TBI)], 186 patients treated with 12 mg/kg busulphan plus 140 mg/m2 melphalan (BUMEL) and 28 patients treated with 14 mg/kg busulphan followed by cyclophosphamide 120 mg/kg (BUCY). There were no significant differences in respect to either transplant related death or haematological recovery, regardless of growth factor use, between the four conditioning programs. Nevertheless, hospitalization time with MEL200 was less than with BUMEL when growth factors were used (19+/-9 vs. 25+/-9 days, P = 0.009) and less than with MEL140 + TBI without growth factors (20+/-8 days vs. 27+/-9 days, P = 0.002). In patients with measurable disease at ASCT (non-complete remission [CR]), BUMEL achieved a 51% CR vs. 43%-31% in the other groups (P = 0.007). The response rate for patients in partial remission (PR) at ASCT was 100% with BUMEL vs. 93%-86% in the other groups (P between 0.02 and 0.0007). The median overall survival (OS) for the BUMEL group was 57 months (95% confidence interval [CI]: 51-78) as compared to 45 (CI: 36-64) months for the MEL200 group and 39 (CI: 28-72) months for the MEL140 + TBI and BUCY groups. The median event free survival (EFS) was longer in the BUMEL group [30 (CI: 22-44) mo] than in the MEL200 [22 (CI: 18-26) mo], BUCY [23 (CI: 11-50) mo] or MEL140 + TBI groups [20 (CI: 15-29) mo]. Nevertheless, the differences in OS and EFS did not reach statistical significance in either the univariate analysis or the multivariate analysis adjusted with other high prognostic weight factors. As in the initial study, differences in regards to the anti-myeloma effect of the conditioning regimens are not conclusive. However, the better response rates associated with the favorable tendency in outcome achieved with BUMEL, continue to justify further prospective studies." @default.
• W2076756910 created "2016-06-24" @default.
• W2076756910 creator A5003420715 @default.
• W2076756910 creator A5004401859 @default.
• W2076756910 creator A5005056682 @default.
• W2076756910 creator A5005203836 @default.
• W2076756910 creator A5020853131 @default.
• W2076756910 creator A5023478935 @default.
• W2076756910 creator A5025735313 @default.
• W2076756910 creator A5029958963 @default.
• W2076756910 creator A5031837957 @default.
• W2076756910 creator A5034182883 @default.
• W2076756910 creator A5034430204 @default.
• W2076756910 creator A5035799376 @default.
• W2076756910 creator A5045740475 @default.
• W2076756910 creator A5051874692 @default.
• W2076756910 creator A5056008137 @default.
• W2076756910 creator A5056561414 @default.
• W2076756910 creator A5059466708 @default.
• W2076756910 creator A5071523383 @default.
• W2076756910 creator A5073093146 @default.
• W2076756910 creator A5075722788 @default.
• W2076756910 creator A5076408649 @default.
• W2076756910 creator A5082070242 @default.
• W2076756910 creator A5087171473 @default.
• W2076756910 creator A5088242526 @default.
• W2076756910 date "2002-01-01" @default.
• W2076756910 modified "2023-10-18" @default.
• W2076756910 title "Myeloablative Treatments for Multiple Myeloma: Update of a Comparative Study of Different Regimens Used in Patients from the Spanish Registry for Transplantation in Multiple Myeloma" @default.
• W2076756910 cites W1499718350 @default.
• W2076756910 cites W1791616244 @default.
• W2076756910 cites W1840931904 @default.
• W2076756910 cites W1887989049 @default.
• W2076756910 cites W1959587708 @default.
• W2076756910 cites W1964073968 @default.
• W2076756910 cites W1995310604 @default.
• W2076756910 cites W1995984173 @default.
• W2076756910 cites W2026295989 @default.
• W2076756910 cites W2032367428 @default.
• W2076756910 cites W20342555 @default.
• W2076756910 cites W2042892109 @default.
• W2076756910 cites W2064931441 @default.
• W2076756910 cites W2066432900 @default.
• W2076756910 cites W2069746327 @default.
• W2076756910 cites W2130358507 @default.
• W2076756910 cites W2176620224 @default.
• W2076756910 cites W2206832861 @default.
• W2076756910 cites W2254708349 @default.
• W2076756910 cites W2322962980 @default.
• W2076756910 cites W2433538213 @default.
• W2076756910 cites W3145716452 @default.
• W2076756910 cites W4237181574 @default.
• W2076756910 cites W4238509480 @default.
• W2076756910 cites W4378951223 @default.
• W2076756910 cites W98986799 @default.
• W2076756910 doi "https://doi.org/10.1080/10428190210194" @default.
• W2076756910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11908738" @default.
• W2076756910 hasPublicationYear "2002" @default.
• W2076756910 type Work @default.
• W2076756910 sameAs 2076756910 @default.
• W2076756910 citedByCount "47" @default.
• W2076756910 countsByYear W20767569102012 @default.
• W2076756910 countsByYear W20767569102013 @default.
• W2076756910 countsByYear W20767569102016 @default.
• W2076756910 countsByYear W20767569102017 @default.
• W2076756910 countsByYear W20767569102018 @default.
• W2076756910 countsByYear W20767569102019 @default.
• W2076756910 countsByYear W20767569102020 @default.
• W2076756910 countsByYear W20767569102021 @default.
• W2076756910 countsByYear W20767569102023 @default.
• W2076756910 crossrefType "journal-article" @default.
• W2076756910 hasAuthorship W2076756910A5003420715 @default.
• W2076756910 hasAuthorship W2076756910A5004401859 @default.
• W2076756910 hasAuthorship W2076756910A5005056682 @default.
• W2076756910 hasAuthorship W2076756910A5005203836 @default.
• W2076756910 hasAuthorship W2076756910A5020853131 @default.
• W2076756910 hasAuthorship W2076756910A5023478935 @default.
• W2076756910 hasAuthorship W2076756910A5025735313 @default.
• W2076756910 hasAuthorship W2076756910A5029958963 @default.
• W2076756910 hasAuthorship W2076756910A5031837957 @default.
• W2076756910 hasAuthorship W2076756910A5034182883 @default.
• W2076756910 hasAuthorship W2076756910A5034430204 @default.
• W2076756910 hasAuthorship W2076756910A5035799376 @default.
• W2076756910 hasAuthorship W2076756910A5045740475 @default.
• W2076756910 hasAuthorship W2076756910A5051874692 @default.
• W2076756910 hasAuthorship W2076756910A5056008137 @default.
• W2076756910 hasAuthorship W2076756910A5056561414 @default.
• W2076756910 hasAuthorship W2076756910A5059466708 @default.
• W2076756910 hasAuthorship W2076756910A5071523383 @default.
• W2076756910 hasAuthorship W2076756910A5073093146 @default.
• W2076756910 hasAuthorship W2076756910A5075722788 @default.
• W2076756910 hasAuthorship W2076756910A5076408649 @default.
• W2076756910 hasAuthorship W2076756910A5082070242 @default.
• W2076756910 hasAuthorship W2076756910A5087171473 @default.
• W2076756910 hasAuthorship W2076756910A5088242526 @default.
• W2076756910 hasConcept C126322002 @default.
• W2076756910 hasConcept C141071460 @default.
• W2076756910 hasConcept C2776364478 @default.

• next